Same Indication

Ondansetron vs Osimertinib

Ondansetron vs Osimertinib: Overview

This comparison examines the pharmacological differences between Ondansetron and Osimertinib.

Mechanism of Action

Ondansetron: Selective 5-HT3 receptor antagonist.

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Pharmacokinetics

Half-life: Ondansetron — 3-5 hours; Osimertinib — 48 hours.

Chemical Properties

Molecular Formula: Ondansetron — C18H19N3O; Osimertinib — C28H33N7O2.

Molecular Weight: Ondansetron — 293.3660 g/mol; Osimertinib — 499.6050 g/mol.

Type: Ondansetron — Small molecule; Osimertinib — Small molecule.